🎙️ podcast Analysis December 18, 2025 Investing Experts

The Dividend Surgeon: Cutting Through Chemical Sector Carnage

Specialty Chemicals REIT - Retail Regional Banking
Tickers
3 Picks
Conviction MEDIUM
Risk Profile 2.3/10 (MODERATE RISK)
Horizon 12-18 months
Signal Snapshot Core Theme: Dividend Growth Investing

High yields signal distressed value opportunities

Asset sales funding dividends create deteriorating cycles

Cyclical Recovery; Rate Cuts; Dividend Normalization

Executive Summary

Scott Kaufman's dividend analysis reveals a surgical approach to chemical sector distress that contradicts surface-level value signals. While LyondellBasell trades at a 12.6% yield after falling 42% this year, Kaufman's framework exposes a dividend trap: the company has been selling assets to fund distributions and won't achieve coverage until beyond 2027. Eastman Chemical, despite appearing less attractive with a 5.22% yield, maintains superior dividend coverage and trades closer to fair value. This divergence illustrates how yield-chasing investors miss fundamental deterioration. Kaufman's 10-year PE normalization methodology and cash flow-first analysis provide a systematic filter for identifying sustainable dividend growth versus unsustainable distributions. His model portfolio targets 6-8% yields through a 60-40 common equity to fixed income split, with 21 current holdings building toward 42. The framework's emphasis on companies that don't require debt or asset sales to fund dividends creates a natural screen for quality. Regional banking exposure through Regions Financial capitalizes on sector-wide fear despite strong fundamentals, while REIT positioning in Realty Income leverages yield spread dynamics versus treasury rates. The approach systematically avoids dividend cuts through coverage analysis while capturing mean reversion opportunities in cyclical sectors.

Key Insights

01 Key Insight
Dividend coverage analysis reveals LyondellBasell's 12.6% yield is a trap, with coverage not expected until beyond 2027
what Scott Kaufman said

“The dividend isn't expected to be covered until beyond 2027. And so even though offhand, it looks like it might be a better value than Eastman Johnson because it's been down 42% this year, we can actually see that it's not that attractive overall.”

Investment Implication High-yield chemical stocks may be value traps where asset sales to fund dividends create a deteriorating cycle, making lower-yielding but covered dividends more attractive

This is a preview. Log in to see the full analysis including investment opportunities, risks, catalysts, and detailed insights.


Next:
The Free Cash Flow Yield Revolution: Betting Against the Echo Bubble →

Travis Koldus argues we're in an 'Echo Bubble' reminiscent of Japan 1989, where the US represents 62% of global market…

Investment Disclaimer: StackAlpha provides information and analysis tools for educational purposes only. Nothing on this platform constitutes investment advice, and you should not rely solely on this information for investment decisions. Past performance does not guarantee future results. Always consult with qualified financial advisors before making investment decisions. Full Disclaimer